Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform

被引:75
作者
Sista, Ramakrishna S. [1 ]
Wang, Tong [1 ]
Wu, Ning [1 ]
Graham, Carrie [1 ]
Eckhardt, Allen [1 ]
Winger, Theodore [1 ]
Srinivasan, Vijay [1 ]
Bali, Deeksha [2 ]
Millington, David S. [2 ]
Pamula, Vamsee K. [1 ]
机构
[1] Adv Liquid Log Inc, Res Triangle Pk, NC 27709 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27713 USA
基金
美国国家卫生研究院;
关键词
Newborn screening; Lysosomal storage disease; Digital microfluidics; Dried blood spot; High throughput; Multiplex enzymatic assay; LYSOSOMAL STORAGE DISORDERS; TANDEM MASS-SPECTROMETRY; DRIED BLOOD SPOTS; ASSAY;
D O I
10.1016/j.cca.2013.05.001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Purpose: New therapies for lysosomal storage diseases (LSDs) have generated interest in screening newborns for these conditions. We present performance validation data on a digital microfluidic platform that performs multiplex enzymatic assays for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases. Methods: We developed an investigational disposable digital microfluidic cartridge that uses a single dried blood spot (DBS) punch for performing a 5-plex fluorometric enzymatic assay on up to 44 DBS samples. Precision and linearity of the assays were determined by analyzing quality control DBS samples; clinical performance was determined by analyzing 600 presumed normal and known affected samples (12 for Pompe, 7 for Fabry and 10 each for Hunter, Gaucher and Hurler). Results: Overall coefficient of variation (CV) values between cartridges, days, instruments, and operators ranged from 2 to 21%; linearity correlation coefficients were >= 0.98 for all assays. The multiplex enzymatic assay performed from a single DBS punch was able to discriminate presumed normal from known affected samples for 5 LSDs. Conclusions: Digital microfluidic technology shows potential for rapid, high-throughput screening for 5 LSDs in a newborn screening laboratory environment. Sample preparation to enzymatic activity on each cartridge is less than 3 h. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 2018, CLSI EV LIN QUANT ME
[2]   A Pilot Newborn Screening Program for Lysosomal Storage Disorders (LSD) in Illinois [J].
Burton, Barbara ;
Charrow, Joel ;
Angle, Brad ;
Widera, Shanna ;
Waggoner, Darrel .
MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) :S23-S24
[3]   Development and Evaluation of Quality Control Dried Blood Spot Materials in Newborn Screening for Lysosomal Storage Disorders [J].
De Jesus, Victor R. ;
Zhang, X. Kate ;
Keutzer, Joan ;
Bodamer, Olaf A. ;
Muehl, Adolf ;
Orsini, Joseph J. ;
Caggana, Michele ;
Vogt, Robert F. ;
Hannon, W. Harry .
CLINICAL CHEMISTRY, 2009, 55 (01) :158-164
[4]   A Tandem Mass Spectrometry Triplex Assay for the Detection of Fabry, Pompe, and Mucopolysaccharidosis-I (Hurler) [J].
Duffey, Trisha A. ;
Bellamy, Garland ;
Elliott, Susan ;
Fox, Angela C. ;
Glass, Michael ;
Turecek, Frantisek ;
Gelb, Michael H. ;
Scott, C. Ronald .
CLINICAL CHEMISTRY, 2010, 56 (12) :1854-1861
[5]  
Graham C, 2011, 2011 APHL ANN M
[6]  
GUTHRIE R, 1963, PEDIATRICS, V32, P338
[7]   Newborn screening for neuropathic lysosomal storage disorders [J].
Hwu, Wuh-Liang ;
Chien, Yin-Hsiu ;
Lee, Ni-Chung .
JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (04) :381-386
[8]   Newborn Screening for Fabry Disease in Taiwan Reveals a High Incidence of the Later-Onset GLA Mutation c.936+919G > A (IVS4+919G > A) [J].
Hwu, Wuh-Liang ;
Chien, Yin-Hsiu ;
Lee, Ni-Chung ;
Chiang, Shu-Chuan ;
Dobrovolny, Robert ;
Huang, Ai-Chu ;
Yeh, Hui-Ying ;
Chao, May-Chin ;
Lin, Shio-Jean ;
Kitagawa, Teruo ;
Desnick, Robert J. ;
Hsu, Li-Wen .
HUMAN MUTATION, 2009, 30 (10) :1397-1405
[9]   Current Enzyme Replacement Therapy for the Treatment of Lysosomal Storage Diseases [J].
Lim-Melia, Elizabeth R. ;
Kronn, David F. .
PEDIATRIC ANNALS, 2009, 38 (08) :448-455
[10]   Newborn Screening of Lysosomal Storage Disorders [J].
Marsden, Deborah ;
Levy, Harvey .
CLINICAL CHEMISTRY, 2010, 56 (07) :1071-1079